A Randomized Controlled Trial of Dose Reduction of Biologic Therapy in Axial Spondyloarthritis: Rationale and Protocol of an Open-Label Non-inferiority Study and a Review of Literature
Axial spondyloarthritis (SpA) is a spectrum of inflammatory conditions predominantly involving the spine and sacroiliac (SI) joints. The development of biological therapies has revolutionized the treatment paradigm in SpA. This has led to a great improvement in clinical outcomes, including inflammat...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2022-12-01
|
Series: | Journal of Clinical Rheumatology and Immunology |
Subjects: | |
Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341722300105 |